Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
EuroIntervention ; 1(4): 438-44, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19755219

RESUMO

AIMS: To study the 5 month performance of a balloon-expandable percutaneous heart valve (PHV) in the systemic circulation of animals. METHODS AND RESULTS: Moderate-to-severe (>/= grade 3) aortic insufficiency was created in 14 juvenile sheep using a bioptome device. A 23mm PHV was implanted distal to the left subclavian artery (1.78+/-0.18 cm2 area, 27+/-2 mmHg closing gradient). Valve performance was followed angiographically (baseline, 21 weeks) and echocardiographically (baseline, 6, 14, 21 weeks). Animals were euthanized at 21 weeks or at the first sign of valve dysfunction. Four animals died of acute procedural complications (aortic perforation, mitral valve damage, hemothorax, and sheath dissection of brachio-cephalic artery). One animal with a rotated PHV (secondary to aortic dissection) was euthanized at 6 weeks; 3 animals were euthanized at weeks 6 and 14 because of decreased leaflet mobility (normal PHV at autopsy, decreased mobility related to halothane-induced hypotension). Six animals with normal PHV function (1.68+/-0.12 cm2 area, 23+/-4mmHg closing gradient) were euthanized at 21 weeks; pathologic examination revealed no significant PHV abnormalities. Native aortic valve insufficiency was grade 2-4 at 21 weeks. CONCLUSION: PHV function remains satisfactory to 21 weeks in the descending aorta. This animal model is valid for chronic study of PHV in the systemic circulation.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA